or
Remember me
Back
RALI-DxTM Severity/Triage Tests Multi-use Test... Aids in Diagnosing Severity of COVID-19
Influenza or Other Adverse Respiratory Events
> $400 test that measures critical biomarkers predictive of severe “cytokine storm” and respiratory failure
> Early assessment eases capacity at ER
> Patients benefit from improved knowledge and ER staff have a cost-effect tool to discharge with improved confidence
> Triage tool aid doctors in treatment decisions - send patient home or admit to hospital or to treat with advanced respiratory care measures
> Monitoring of patients in the ICU > 25 million ICU Patient Days in North America > 60% Respiratory involvement
> Earlier assessment reduces morbidity, maximizes resources, reduces burden and costs on healthcare system
A daily snapshot of everything from market open to close.